ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,025.00
-55.00 (-2.64%)
At close: Aug 24, 2026

ENBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
36,18333,95335,65434,02434,24033,466
Revenue Growth
7.81%-4.77%4.79%-0.63%2.31%-3.17%
Gross Profit
13,89111,59911,5737,0556,34210,753
Operating Income
1,230917.421,378-3,354-4,7771,122
Net Income
574.521,007645.61-6,300-3,4455,245
Earnings Per Share
52.8492.6959.00-580.00-317.00344.00
EPS Growth
270.73%57.10%----

Revenue by Segment

Fiscal YearFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '23 Dec '22 Dec '21 Dec '20
Disinfectant
12,9919,2298,28112,40212,697
Pesticide
12,61810,8616,39710,14011,664
Herbicide
6,8306,6079,6647,5706,083
Sterile Insecticide
4,1202,7284,2111,5892,043
Merchandised Products
890.371,8842,07379.79611.9
Subcontracting
673.79506.721,0961,023658.32
Product - Others
-2,4692,2091,191662.46806.15

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,6924,9793,0495,00315,56725,165
Total Debt
24,47214,05614,80313,12722,28520,401
Net Cash (Debt)
-19,780-9,077-11,754-8,125-6,7184,764
Net Cash Growth
------
Net Cash Per Share
-1819.20-835.24-1074.14-747.93-618.26423.44

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
5,0309,0884,90110,921-8,499-2,289
Capital Expenditures
-10,760-6,821-8,665-154.67-179.67-2,915
Free Cash Flow
-5,7302,267-3,76310,766-8,679-5,205
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
38.39%34.16%32.46%20.73%18.52%32.13%
Operating Margin
3.40%2.70%3.86%-9.86%-13.95%3.35%
Pretax Margin
1.80%3.54%2.48%-23.69%-11.19%18.31%
Profit Margin
1.59%2.97%1.81%-18.52%-10.06%15.67%
FCF Margin
-15.84%6.68%-10.55%31.64%-25.35%-15.55%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
38.3224.5534.00--16.47
Forward PE
-14.7514.7514.7514.7514.75
P/FCF Ratio
-10.91-3.54--
PS Ratio
0.610.730.621.121.352.58